Due to the aggressive nature and high reoccurence rate, the prognosis for<unk>  is generally very poor. Most patients die within 6 months and only 3%<unk> more than 2 years. A recent case report suggest that the prognosis of<unk>  may be improving.
Liver angiosarcoma
Cholangiosarcoma
Cavernous liver hemangioma
Cholangiocarcinoma
Pancreatoblastoma
Liver abscess
Hepatoblastoma
Periampullary cancer